Tengfei Zhang Selected Research

COVID-19

12/2020

Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tengfei Zhang Research Topics

Disease

20	Neoplasms (Cancer) 08/2022 - 01/2011
7	Adenocarcinoma of Lung 08/2022 - 01/2018
6	Infections 01/2022 - 01/2016
5	Lung Neoplasms (Lung Cancer) 08/2022 - 01/2018
5	Adenocarcinoma 01/2022 - 01/2018
4	Necrosis 01/2021 - 01/2018
4	Esophageal Squamous Cell Carcinoma 01/2015 - 11/2011
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2017
3	Inflammation (Inflammations) 01/2021 - 01/2018
3	Hypoxia (Hypoxemia) 11/2020 - 01/2018
3	Newcastle Disease 05/2020 - 06/2015
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2019
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2018 - 01/2018
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2015
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 10/2018
2	Liver Neoplasms (Liver Cancer) 01/2022 - 01/2021
2	Neoplasm Metastasis (Metastasis) 03/2021 - 01/2019
2	Vomiting 08/2020 - 01/2019
2	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2011
2	Carcinogenesis 01/2019 - 10/2017
2	Lymphoma (Lymphomas) 01/2018 - 10/2015
2	Asthma (Bronchial Asthma) 07/2010 - 03/2010
1	Myocardial Infarction 06/2022
1	Vaccine-Preventable Diseases 01/2022
1	Gastroenteritis 01/2022
1	Hemorrhage 01/2022
1	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Coinfection 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	COVID-19 12/2020
1	Bradycardia 08/2020
1	Necrotizing Enterocolitis 08/2020
1	Diarrhea 08/2020
1	Overweight 01/2020
1	Campylobacter Infections (Campylobacter Infection) 01/2020
1	Cholera 06/2019

Drug/Important Bio-Agent (IBA)

8	CytokinesIBA 01/2021 - 07/2010
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2011
5	VaccinesIBA 01/2022 - 06/2015
4	AntigensIBA 12/2020 - 03/2010
4	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2018
3	Biological ProductsIBA 01/2022 - 01/2015
3	AntibodiesIBA 12/2020 - 11/2016
3	InterleukinsIBA 10/2020 - 01/2018
3	Interleukin-6 (Interleukin 6)IBA 10/2020 - 01/2018
3	CrizotinibIBA 01/2019 - 01/2018
2	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2017
2	Long Noncoding RNAIBA 01/2022 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	ChemokinesIBA 03/2021 - 01/2016
2	Interleukin-8 (Interleukin 8)IBA 10/2020 - 01/2020
2	TeaIBA 01/2020 - 05/2017
2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 10/2018
2	Proteins (Proteins, Gene)FDA Link 06/2019 - 10/2017
2	osimertinibIBA 05/2019 - 01/2018
2	cabozantinibIBA 05/2019 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 02/2019 - 01/2016
2	Pharmaceutical PreparationsIBA 02/2019 - 01/2018
2	Chimeric Antigen ReceptorsIBA 01/2018 - 10/2015
2	AfatinibIBA 01/2018 - 01/2018
2	Metformin (Glucophage)FDA LinkGeneric 01/2018 - 01/2018
2	Insulin-Like PeptidesIBA 10/2017 - 10/2014
2	Messenger RNA (mRNA)IBA 01/2015 - 03/2010
1	Immune Checkpoint InhibitorsIBA 08/2022
1	Pemetrexed (MTA)FDA Link 08/2022
1	Carboplatin (JM8)FDA LinkGeneric 08/2022
1	camrelizumabIBA 08/2022
1	AcidsIBA 06/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	geranylgeranyl pyrophosphate (geranylgeranyl diphosphate)IBA 01/2022
1	Competitive Endogenous RNAIBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2022
1	Mevalonic Acid (Mevalonate)IBA 01/2022
1	FluoroquinolonesIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Caspase 3 (Caspase-3)IBA 12/2020
1	InterferonsIBA 12/2020
1	Neutralizing AntibodiesIBA 12/2020
1	Immunoglobulin G (IgG)IBA 12/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020
1	Immunologic Factors (Immunomodulators)IBA 11/2020
1	ThymosinIBA 11/2020
1	RNA Splicing FactorsIBA 10/2020
1	Fibrinogen (Factor I)FDA Link 08/2020
1	Interleukin-12 (IL 12)IBA 08/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	LipidsIBA 01/2020
1	Erythromycin (Erycette)FDA LinkGeneric 01/2020
1	MacrolidesIBA 01/2020
1	BilirubinIBA 01/2020
1	Small Interfering RNA (siRNA)IBA 06/2019
1	Nucleic AcidsIBA 06/2019
1	IronIBA 06/2019

Therapy/Procedure

9	Therapeutics 01/2022 - 01/2011
6	Drug Therapy (Chemotherapy) 08/2022 - 10/2014
4	Immunotherapy 06/2019 - 01/2015
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2019 - 03/2010
1	Radiotherapy 03/2021